Image of Gael McGill

Gael McGill, PhD

Lecturer on Biological Chemistry and Molecular Pharmacology, Harvard Medical School
Founder & CEO, Digizyme, Inc.
digizyme.com

Gaël McGill is faculty and director of Molecular Visualization at the Center for Molecular and Cellular Dynamics at Harvard Medical School, where his teaching and research focuses on visualization design and assessment methods in science education.  He is also the founder & CEO of Digizyme, Inc. (www.digizyme.com), a firm dedicated to the visualization and communication of science. Dr. McGill co-authored with E.O. Wilson and served as digital director for E.O. Wilson’s Life on Earth digital biology textbook, Apple’s flagship iBook.  He is the creator of the scientific visualization online community portal Clarafi.com and the Molecular Maya (mMaya) software toolkit, as well as contributing to leading Maya and ZBrush textbooks for Wiley/SYBEX Publishing.  Dr. McGill was also a board member of the Vesalius Trust and remains an advisor to several biotechnology and device companies.  After his B.A. summa cum laude in Biology, Music, and Art History from Swarthmore College and Ph.D. at Harvard Medical School as a Howard Hughes Medical Institute and Sandoz Pharmaceuticals fellow, Dr. McGill completed his postdoctoral work at the Dana Farber Cancer Institute studying tumor cell apoptosis and melanoma.

View more Master of Science in Media, Medicine, and Health Faculty here.

View more Media and Medicine Certificate program faculty here. 

Knowledge synthesis through scientific visualization.
Authors: Authors: McGill GG.
Nat Microbiol
View full abstract on Pubmed
Conformational dynamics data bank: a database for conformational dynamics of proteins and supramolecular protein assemblies.
Authors: Authors: Kim DN, Altschuler J, Strong C, McGill G, Bathe M.
Nucleic Acids Res
View full abstract on Pubmed
Molecular movies... coming to a lecture near you.
Authors: Authors: McGill G.
Cell
View full abstract on Pubmed
TFE3 fusions activate MET signaling by transcriptional up-regulation, defining another class of tumors as candidates for therapeutic MET inhibition.
Authors: Authors: Tsuda M, Davis IJ, Argani P, Shukla N, McGill GG, Nagai M, Saito T, Laé M, Fisher DE, Ladanyi M.
Cancer Res
View full abstract on Pubmed
c-Met expression is regulated by Mitf in the melanocyte lineage.
Authors: Authors: McGill GG, Haq R, Nishimura EK, Fisher DE.
J Biol Chem
View full abstract on Pubmed
NF-kappa B2 p100 is a pro-apoptotic protein with anti-oncogenic function.
Authors: Authors: Wang Y, Cui H, Schroering A, Ding JL, Lane WS, McGill G, Fisher DE, Ding HF.
Nat Cell Biol
View full abstract on Pubmed
Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability.
Authors: Authors: McGill GG, Horstmann M, Widlund HR, Du J, Motyckova G, Nishimura EK, Lin YL, Ramaswamy S, Avery W, Ding HF, Jordan SA, Jackson IJ, Korsmeyer SJ, Golub TR, Fisher DE.
Cell
View full abstract on Pubmed